                         SEQUENCE LISTING

<110>  MOREHOUSE SCHOOL OF MEDICINE
       BOND, Vincent Craig et al.
 
<120>  COMPOSITIONS AND METHODS FOR TREATING SARS-CoV-2 INFECTIONS

<130>  1013-588 PCT

<160>  52    

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: SMR peptide

<400>  1

Val Gly Phe Pro Val 
1               5   


<210>  2
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: SMR peptide

<400>  2

Val Gly Phe Pro Val Ala Ala Val Gly Phe Pro Val 
1               5                   10          


<210>  3
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: CPP peptide

<400>  3

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln 
1               5                   10              


<210>  4
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: SMR-CPP peptide

<400>  4

Val Gly Phe Pro Val Ala Ala Val Gly Phe Pro Val Gly Arg Lys Lys 
1               5                   10                  15      


Arg Arg Gln Arg Arg Arg Pro Pro Gln 
            20                  25  


<210>  5
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: Clu-BP peptide

<400>  5

His Pro Leu Ser Lys His Pro Tyr Trp Ser Gln Pro 
1               5                   10          


<210>  6
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: Clu-BP peptide

<400>  6

Asn Thr Tyr Trp Ser Gln Leu Leu His Phe Gln Thr 
1               5                   10          


<210>  7
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: Clu-BP peptide

<400>  7

Ser His Ala Leu Pro Leu Thr Trp Ser Thr Ala Ala 
1               5                   10          


<210>  8
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: Mito-T peptide

<400>  8

Met Ser Val Leu Thr Pro Leu Leu Leu Arg Gly Leu Thr Gly Ser Ala 
1               5                   10                  15      


Arg Arg Leu Pro Val Pro Arg Ala Lys Ile His Ser Leu 
            20                  25                  


<210>  9
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: Mito-T peptide

<400>  9

Met Leu Ser Asn Leu Arg Ile Leu Leu Asn Lys Ala Ala Leu Arg Lys 
1               5                   10                  15      


Ala His Thr Ser Met Val Arg Asn Phe Arg Tyr Gly Lys Pro Val Gln 
            20                  25                  30          


Cys 
    


<210>  10
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: Mito-T peptide

<400>  10

Met Leu Ser Leu Arg Gln Ser Ile Arg Phe Phe Lys Pro Ala Thr Arg 
1               5                   10                  15      


Thr Leu 
        


<210>  11
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: Mito-T peptide

<400>  11

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210>  12
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: Mito-T peptide

<400>  12

Met Phe Ser Tyr Leu Pro Arg Tyr Pro Leu Arg Ala Ala Ser Ala Arg 
1               5                   10                  15      


Ala Leu Val Arg Ala Thr Arg Pro Ser Tyr Arg Ser Ala Leu Leu Arg 
            20                  25                  30          


Tyr Gln 
        


<210>  13
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: Mito-T peptide

<400>  13

Met Ala Ala Trp Met Arg Ser Leu Phe Ser Pro Leu Lys Lys Leu Trp 
1               5                   10                  15      


Ile Arg Met His 
            20  


<210>  14
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: Mito-T peptide

<400>  14

Met Lys Leu Leu Trp Arg Leu Ile Leu Ser Arg Lys Trp 
1               5                   10              


<210>  15
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: Mito-T peptide

<400>  15

Met Trp Trp Arg Arg Ser Arg Thr Asn Ser Leu Arg Tyr Thr 
1               5                   10                  


<210>  16
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: Mito-T peptide

<400>  16

Met Leu Phe Arg Leu Arg Arg Ser Val Arg Leu Arg Gly Leu Leu Ala 
1               5                   10                  15      


<210>  17
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: Mito-T peptide

<400>  17

Met Trp Thr Leu Gly Arg Arg Ala Val Ala Gly Leu Leu Ala Ser Pro 
1               5                   10                  15      


Ser Pro Ala Gln 
            20  


<210>  18
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: Mito-T peptide

<400>  18

Arg Arg Ile Val Val Leu His Gly Tyr Gly Ala Val Lys Glu Val Leu 
1               5                   10                  15      


Leu Asn His Lys 
            20  


<210>  19
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: Mito-T peptide

<400>  19

Met Leu Ser Leu Arg Gln Asp Ile Arg Phe Phe Lys Pro Ala Thr Arg 
1               5                   10                  15      


Thr Leu Cys Ser Ser Arg 
            20          


<210>  20
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: anti-fusion peptide

<400>  20

Ser Leu Asp Gln Ile Asn Val Thr Phe Leu Asp Leu Glu Tyr Glu Met 
1               5                   10                  15      


Lys Lys Leu Glu Glu Ala Ile Lys Lys Leu Glu Glu Ser Tyr Ile Asp 
            20                  25                  30          


Leu Lys Glu Leu 
        35      


<210>  21
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: anti-fusion peptide

<400>  21

Ile Ser Gly Ile Asn Ala Ser Val Val Asn Ile Gln Lys Glu Ile Asp 
1               5                   10                  15      


Arg Leu Asn Glu Val Ala Lys Asn Leu Asn Glu Ser Leu Ile Asp Leu 
            20                  25                  30          


Gln Glu Leu 
        35  


<210>  22
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: anti-fusion peptide

<400>  22

Ile Ser Gly Ile Asn Ala Ser Val Val Asn Ile Gln Lys Glu Ile Asp 
1               5                   10                  15      


Arg Leu Asn Glu Val Ala Lys Asn Leu Asn Glu Ser Leu Ile Asp Leu 
            20                  25                  30          


Gln Glu Leu Lys 
        35      


<210>  23
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: anti-fusion peptide

<400>  23

Asp Ile Ser Gly Ile Asn Ala Ser Val Val Asn Ile Gln Lys Glu Ile 
1               5                   10                  15      


Asp Arg Leu Asn Glu Val Ala Lys Asn Leu Asn Glu Ser Leu Ile Asp 
            20                  25                  30          


Leu Gln Glu Leu 
        35      


<210>  24
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: viral attachment inhibitor peptide

<400>  24

Tyr Lys Tyr Arg Tyr Leu 
1               5       


<210>  25
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: viral attachment inhibitor peptide

<400>  25

Phe Leu Asp Lys Phe Asn His Glu Ala Glu Asp Leu Phe Tyr Gln Ser 
1               5                   10                  15      


Ser Leu 
        


<210>  26
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: viral attachment inhibitor peptide

<400>  26

Glu Glu Gln Ala Lys Thr Phe Leu Asp Lys Phe Asn His Glu Ala Glu 
1               5                   10                  15      


Asp Leu Phe Tyr Gln Ser Ser Gly Leu Gly Lys Gly Asp Phe Arg 
            20                  25                  30      


<210>  27
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: viral attachment inhibitor peptide

<400>  27

Gly Phe Leu Tyr Val Tyr Lys Gly Tyr Gln Pro Ile 
1               5                   10          


<210>  28
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: viral attachment inhibitor peptide

<400>  28

Phe Tyr Thr Thr Thr Gly Ile Gly Tyr Gln Pro Tyr 
1               5                   10          


<210>  29
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: viral attachment inhibitor peptide

<400>  29

Ser Thr Ser Gln Lys Ser Ile Val Ala Tyr Thr Met 
1               5                   10          


<210>  30
<211>  45
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: viral attachment inhibitor peptide

<400>  30

Gly Gly Gly Tyr Ser Lys Ala Gln Lys Ala Gln Ala Lys Gln Ala Lys 
1               5                   10                  15      


Gln Ala Gln Lys Ala Gln Lys Ala Gln Ala Lys Gln Ala Lys Gln Ala 
            20                  25                  30          


Gln Lys Ala Gln Lys Ala Gln Ala Lys Gln Ala Lys Gln 
        35                  40                  45  


<210>  31
<211>  80
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: viral attachment inhibitor peptide

<400>  31

Gly Ser His Met Gly Asp Ala Gln Asp Lys Leu Lys Tyr Leu Val Lys 
1               5                   10                  15      


Gln Leu Glu Arg Ala Leu Arg Glu Leu Lys Lys Ser Leu Asp Glu Leu 
            20                  25                  30          


Glu Arg Ser Leu Glu Glu Leu Glu Lys Asn Pro Ser Glu Asp Ala Leu 
        35                  40                  45              


Val Glu Asn Asn Arg Leu Asn Val Glu Asn Asn Lys Ile Ile Val Glu 
    50                  55                  60                  


Val Leu Arg Ile Ile Leu Glu Leu Ala Lys Ala Ser Ala Lys Leu Ala 
65                  70                  75                  80  


<210>  32
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: PEG-endo-cleavage-SMR peptide


<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa can be any naturally occurring amino acid

<400>  32

Asn Xaa Asn Val Gly Phe Pro Val Ala Ala Val Gly Phe Pro Val 
1               5                   10                  15  


<210>  33
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: PEG-endo-cleavage-SMR-Clu-BP peptide


<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa can be any naturally occurring amino acid

<400>  33

Asn Xaa Asn Val Gly Phe Pro Val Ala Ala Val Gly Phe Pro Val His 
1               5                   10                  15      


Pro Leu Ser Lys His Pro Tyr Trp Ser Gln Pro 
            20                  25          


<210>  34
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: endo-cleavage

<400>  34

Pro Leu Gly Leu Ala Gly 
1               5       


<210>  35
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: endo-cleavage


<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  METHYLATION

<400>  35

Pro Leu Gly Cys Ala Gly 
1               5       


<210>  36
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: endo-cleavage

<400>  36

Arg Pro Leu Ala Leu Trp Arg Ser 
1               5               


<210>  37
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: endo-cleavage

<400>  37

Glu Ser Pro Ala Tyr Tyr Thr Ala 
1               5               


<210>  38
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: endo-cleavage

<400>  38

Asp Pro Arg Ser Phe Leu 
1               5       


<210>  39
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: endo-cleavage

<400>  39

Pro Pro Arg Ser Phe Leu 
1               5       


<210>  40
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: endo-cleavage

<400>  40

Arg Leu Gln Leu Lys Leu 
1               5       


<210>  41
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: endo-cleavage


<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  ACETYLATION

<400>  41

Arg Leu Gln Leu Lys 
1               5   


<210>  42
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: endo-cleavage


<220>
<221>  misc_feature
<222>  (2)..(3)
<223>  Xaa can be any naturally occurring amino acid

<400>  42

Arg Xaa Xaa Arg 
1               


<210>  43
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: endo-cleavage


<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  Xaa is Lys or Arg

<400>  43

Arg Xaa Xaa Arg 
1               


<210>  44
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: endo-cleavage


<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa is Glu or Asp

<400>  44

Ile Xaa Gly Arg 
1               


<210>  45
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: endo-cleavage

<400>  45

Leu Val Pro Arg Gly Ser 
1               5       


<210>  46
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: SMR-Clu-BP

<400>  46

Val Gly Phe Pro Val Ala Ala Val Gly Phe Pro Val His Pro Leu Ser 
1               5                   10                  15      


Lys His Pro Tyr Trp Ser Gln Pro 
            20                  


<210>  47
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: SMR-Clu-BP

<400>  47

Val Gly Phe Pro Val Ala Ala Val Gly Phe Pro Val Ala Ala His Pro 
1               5                   10                  15      


Leu Ser Lys His Pro Tyr Trp Ser Gln Pro 
            20                  25      


<210>  48
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: SMR-Clu-BP

<400>  48

Val Gly Phe Pro Val Ala Ala Val Gly Phe Pro Val Ala Ala His Pro 
1               5                   10                  15      


Leu Ser Lys His Pro Tyr Trp Ser Gln Pro Ala Ala His Pro Leu Ser 
            20                  25                  30          


Lys His Pro Tyr Trp Ser Gln Pro 
        35                  40  


<210>  49
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: SMRmut-Clu-BP


<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa can be any naturally occurring amino acid

<400>  49

Asn Xaa Asn Ala Gly Phe Pro Val Ala Ala Ala Gly Phe Pro Val His 
1               5                   10                  15      


Pro Leu Ser Lys His Pro Tyr Trp Ser Gln Pro 
            20                  25          


<210>  50
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: SMRmut-CPP

<400>  50

Ala Gly Phe Pro Val Ala Ala Ala Gly Phe Pro Val Gly Arg Lys Lys 
1               5                   10                  15      


Arg Arg Gln Arg Arg Arg Pro Pro Gln 
            20                  25  


<210>  51
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: SMRmut

<400>  51

Ala Gly Phe Pro Val 
1               5   


<210>  52
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic: SMRmut

<400>  52

Ala Gly Phe Pro Val Ala Ala Ala Gly Phe Pro Val 
1               5                   10          


